Introduction: Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) and CPP-ACP with fluoride (CPP-ACFP) have been shown to provide bioavailable ions to promote mineralization. Hence, the aim of this study was to evaluate the materials' biocompatibility and osteogenic/calcification potential for endodontic applications. Methods: Human and mouse osteoblastlike and fibroblast-like cell lines were incubated with 0.05%-3.0% w/v CPP-ACP and CPP-ACFP, and toxicity, proliferation, alkaline phosphatase, interleukin (IL)-1a, and IL-6 production, collagen type I, osteocalcin, and osteopontin production, and mineralization/calcification were determined. Results: CPP-ACP and CPP-ACFP were non-toxic and had no significant effect on proliferation or production of the inflammatory cytokine IL-1a. Alkaline phosphatase activity of the osteoblast-like cells was significantly increased (P < .05) by CPP-ACP and CPP-ACFP, as was the production of the osteotropic cytokine IL-6, the formation of calcium mineral deposits, and the secretion of mineralization-related proteins (collagen type I and osteocalcin). Conclusions: CPP-ACP and CPP-ACFP are biocompatible and have the potential to induce osteoblastic differentiation and mineralization. Potential applications include apexification, perforation repair, vital pulp therapy, and regenerative endodontic procedures. (J Endod 2018;44:452-457) 
T he mechanism of action of endodontic repair cements that are based on calcium hydroxide and calcium silicate, such as mineral trioxide aggregate, depends on their bioactivity represented by their ability to release ions such as calcium (Ca 2+ ) and hydroxide (OH -). Calcium silicate-based cements that release Ca 2+ enhance hard tissue-forming cell viability, proliferation, and differentiation, and the OH -release increases the alkalinity of the environment that supports hard tissue repair and active calcification (1, 2) . Released Ca 2+ from endodontic repair cements stimulates the expression of mineralization-associated genes such as bone morphogenetic protein-2, collagen 1, and osteocalcin (3) (4) (5) . The release of high concentrations of Ca 2+ from the repair cement at the pulpal site activates the migration of pre-odontoblasts located in the central pulp (6, 7) . Ca 2+ released from repair cements may serve as a bioactive signal that promotes the process of cell-based tissue repair. However, the high pH of calcium hydroxide may not be optimal for cell-based repair mechanisms, and modification of cements to improve their physical and biological properties shows promising results (2) .
Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) is a phosphopeptide stabilized Ca 2+ and phosphate ion (P i ) complex that provides bioavailable Ca 2+ at neutral pH and promotes remineralization of enamel and dentin (8) . A fluoridecontaining version (casein phosphopeptide-amorphous calcium fluoride phosphate [CPP-ACFP]) has superior remineralizing efficacy compared with CPP-ACP (9) . In vitro, calcium-enriched CPP induced Ca 2+ uptake by osteoblast-like cells, promoted osteoblastic differentiation, increased the level and activity of alkaline phosphatase (ALP), and enhanced the formation of calcified nodules (10, 11) . Therefore, CPP-ACP may play a role in promoting osteogenesis and calcification. Furthermore, the addition of CPP-ACP to calcium silicate-based cements has been shown to improve ionic release (1); therefore, CPP-ACP added to these materials may help promote dental hard tissue repair.
Therefore, the aims of this study were to examine the effects of CPP-ACP and CPP-ACFP on osteoblast-like and fibroblast-like cell lines to evaluate biocompatibility and osteogenic/calcification potential.
Materials and Methods

Cell Culture
Human (MG-63) and mouse (MC3T3-E1) osteoblast-like cell lines (Sigma-Aldrich, Castle Hill, NSW, Australia) and human (HGF-1) and mouse (NIH3T3) fibroblast-like cell lines (ATCC, Manassas, VA) were cultured in complete alpha minimum essential medium (complete a-MEM), composed of a-MEM supplemented with 10% v/v fetal calf serum, 1 U/mL penicillin, 0.1 mg/mL streptomycin, 1 mmol/L sodium pyruvate, and 2 mmol/L L-glutamine (Sigma-Aldrich). For the mineralization assay, the complete a-MEM was supplemented with 10 mmol/L glycerophosphate and 50 mg/mL ascorbic acid (Sigma-Aldrich) as an osteogenic medium. Cells were maintained in a humidified Heracell 150 incubator (Thermo Fisher Scientific, Lombard, IL) at 37 C and 5% v/v CO 2 .
Preparation of CPP-ACP and CPP-ACFP Solution
The soluble CPP-ACP and CPP-ACFP powders (9) were mixed with complete a-MEM by magnetic stirring for 24 hours and sterilized through a 0.22-mm filter (Corning Incorporated Life Sciences, Bedford, MA). Stock solutions of 3.0% w/v CPP-ACP and 3.0% w/v CPP-ACFP were prepared and serially diluted to 7 concentrations (0.05%, 0.1%, 0.2%, 0.3%, 0.7%, 1.5%, and 3.0% w/v). CPP-ACP, CPP-ACFP. *Denotes significant differences (P < .05) compared with controls (cells in medium alone). OD, optical density.
Cell Proliferation and Cell Cytotoxicity Assays
Cell proliferation and cell cytotoxicity were assessed by using a methyl-thiazol-tetrazolium assay kit (CellTiter 96 Aqueous NonRadioactive Cell Proliferation Assay) and a lactate dehydrogenase assay kit (CytoTox 96 Non-Radioactive Cytotoxicity Assay), respectively, according to the manufacturer's instructions (Promega Corporation, Fitchburg, WI).
ALP Activity
MG-63 and MC3T3-E1 cell lines were subcultured in 24-well culture plates with complete a-MEM (5 Â 10 4 cells/well in 1 mL). After 24 hours, the culture medium was replaced with 1 mL (per well) of different concentrations of CPP-ACP-and CPP-ACFP-modified medium and incubated for 1, 2, and 3 days. Separate sets of cells for the different groups were used for each time interval. Cells cultured with complete a-MEM alone were used as controls. At the end of each incubation period, the cells were washed with phosphate-buffered saline (PBS) (Sigma-Aldrich), 100 mL lysis buffer (2.5% v/v Triton X-114; Sigma-Aldrich) was added to each well, and the plates were incubated for 1 hour at room temperature. The cell lysate (100 mL) was mixed with 150 mL QuantiBlue solution, and ALP activity was measured colorimetrically according to the manufacturer's instructions (Invivogen, San Diego, CA). Six replicate samples were measured for each group.
Measurement of Cytokine Production
To measure human and mouse interleukin (IL)-1a (IL-1a) and IL-6 production, MG-63, MC3T3-E1, HGF-1, and NIH3T3 cells were subcultured in 24-well culture plates with complete a-MEM (5 Â 10 4 cells/well in 1 mL). After 24 hours, the culture medium was replaced with 1 mL (per well) of the different concentrations of CPP-ACP-and CPP-ACFP-modified medium, and the cells were incubated for 3 days. Cells cultured in medium alone were the negative control, and cells cultured in medium with 20 ng/ml Escherichia coli lipopolysaccharide (Invitrogen, San Diego, CA) were the positive control. At the end of the incubation period, the supernatant was collected and stored at -80 C until use. The levels of IL-1a and IL-6 in the supernatant were measured by using a human IL-1a enzyme-linked immunosorbent assay (ELISA) kit (Abcam Australia Pty Ltd, Victoria, VIC, Australia) and human IL-6, mouse IL-1a, and mouse IL-6 ELISA kits (eBioscience, San Diego, CA) according to the manufacturer's instructions. Six replicate samples were tested for each group.
Mineralization Measurements
To assess the role of CPP-ACP and CPP-ACFP in promoting mineralization by osteoblasts, mineralization was induced on confluent MG-63 and MC3T3-E1 cells by the osteogenic medium. Cells were subcultured in 6-well culture plates with complete a-MEM (2 Â 10 5 cells/well in 4 mL). After 48 hours, the culture medium was replaced with 4 mL/well of CPP-ACP or CPP-ACFP medium (1.5% w/v and 3.0% w/v CPP-ACP and 1.5% w/v and 3.0% w/v CPP-ACFP solutions were tested), and cells were incubated for 14 days. Cells cultured with osteogenic medium alone were the control. After 14 days media were collected and stored at -80 C until used for detection of mineralization-associated proteins by immunoblotting and for quantitation of mineralization by using the alizarin red stain (Sigma-Aldrich) method described previously (12) .
Mineralization-associated proteins, collagen type 1 (Col 1), osteocalcin (OC), and osteopontin (OP), were identified in collected media by immunoblotting using standard techniques. Samples with equal amounts of protein (40 mg) measured by using the Micro BCA method (Thermo Fisher Scientific) were prepared by using 4Â lithium dodecyl sulfate sample buffer (Invitrogen) and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis in NuPAGE MOPS SDS running buffer (Life Technologies, Camarillo, CA) at 200 V by using NuPAGE 4-12% Bis-Tris gels (Life Technologies). Then proteins were 
, MA). The membrane was blocked with 5% w/v skim milk in PBS for 1 hour at room temperature and then washed with PBS and incubated overnight at 4 C with primary antibody (rabbit anti-collagen type 1, rabbit anti-osteocalcin, or rabbit anti-osteopontin; Abcam Australia Pty Ltd). The membrane was then washed 3 times with 0.1% v/v Tween-20 in PBS (PBST) with gentle agitation for 15 minutes for each wash, followed by a final wash with PBS alone. After overnight incubation at 4 C with goat anti-rabbit immunoglobulin G horseradish peroxidase-conjugated secondary antibody (Sigma-Aldrich), the membrane was washed 3 times in PBST (15 minutes for each wash) and 1 wash in PBS. Proteins were detected by using Immobilon chemiluminescence reagent (Millipore Corporation, Billerica, MA) and FUJIFILM LAS-300 camera-based imager (FUJIFILM; Berthold Australia Pty Ltd). To quantify the proteins, densitometry was performed by using ImageJ 1.50e (Wayne Rasband; National Institutes of Health, Bethesda, MD).
Statistical Analysis
The data were analyzed by using SPSS version 11.5.0 (SPSS Inc, Chicago, IL). The Kolmogorov-Smirnov test indicated that the data were normally distributed, and therefore, parametric statistical tests were performed (analysis of variance, followed by Tukey test for multiple comparisons). The level of significance was set at P < .05.
Results
Cell Proliferation, Cell Cytotoxicity, and ALP Activity
For the cell lines and CPP-ACP and CPP-ACFP concentrations tested, no significant effect on cell proliferation or toxicity could be detected. For both osteoblast-like cell lines, CPP-ACP and CPP-ACFP increased ALP activity in a dose-related response with 2-fold maxima at CPP-ACP/CPP-ACFP concentrations of 0.1%-1.5% w/v (Fig. 1) . CPP-ACP/CPP-ACFP did not induce the inflammatory cytokine IL-1a in any of the cell lines at any of the concentrations tested (data not Control, 1.5% CPP-ACP, 3% CPP-ACP, 1.5% CPP-ACFP, 3% CPP-ACFP. *Denotes significant differences compared with control group, ie, osteogenic medium alone (P < .05).
shown). The secretion of IL-6 from the osteoblast-like cell lines was significantly increased (P < .05) in a dose-dependent manner when incubated with 0.1%-3.0% w/v CPP-ACP and 0.05%-3.0% w/v CPP-ACFP media when compared with the negative control (Fig. 2) . This effect was significantly greater for CPP-ACFP compared with CPP-ACP. For the 2 fibroblast-like cell lines, neither CPP-ACP nor CPP-ACFP had any significant effect on IL-6 production (Fig. 2) .
Mineralization and Mineralization-related Proteins
The concentrations of alizarin red stain extracted from the osteoblast-like MG-63 cells treated with CPP-ACFP-modified osteogenic media were significantly higher (P < .05) than concentrations of stain extracted from similar cells grown in the control and CPP-ACPmodified osteogenic media (Fig. 3) . MC3T3-E1 cells grown in the CPP-ACFP-and 1.5% w/v CPP-ACP-modified osteogenic media exhibited significantly higher stain concentrations compared with the control (P < .05). MC3T3-E1 cells grown in the 3.0% w/v CPP-ACFP-modified osteogenic medium showed the highest stain concentration (P < .05). CPP-ACP and CPP-ACFP also produced a significant increase (P < .05) in expression of Col 1 and OC and a significant decrease in the expression of OP by the 2 osteoblast-like cell lines (Fig. 4) .
Discussion
Calcium silicate-based cements have wide application in contemporary endodontics including apexification, perforation repair, vital pulp therapy, and regenerative endodontic procedures. However, research continues into improving both their handling properties and biological efficacy (2) . The present study introduces a means to further improve the biological properties and has broad clinical relevance in endodontic therapy as demonstrated by the use of both human and mouse cell lines.
CPP-ACP and CPP-ACFP were not cytotoxic at the concentrations tested and did not significantly change proliferation of the osteoblastlike and fibroblast-like cell lines, confirming the biocompatibility of these phosphopeptide-stabilized ionic complexes. CPP-ACP is Generally Recognized As Safe certified, and previous studies have indicated that the material is biocompatible (10, 13) . The CPP-ACP and CPP-ACFP dose-related increase in ALP activity (an osteoblastic differentiation marker) expressed by the osteoblast-like cell line correlated with the increased expression of the osteotropic cytokine IL-6, Col 1, and OC as well as the increased mineral deposition attributable to the addition of CPP-ACP/CPP-ACFP. ALP is a non-specific phosphomonoesterase and has a role in mineralization by hydrolyzing phosphate esters on a range of molecules to liberate inorganic phosphate (14) . The CPPs contain 5-7 phosphoseryl residues that are phosphoesters and essential for the stabilization of their cargo of calcium and phosphate ions in the ACP ion nanoclusters (8, 15) . ALP will hydrolyze the phosphoseryl residues of the CPP, which will destabilize the ACP nanoclusters, resulting in calcification by the precipitation of hydroxyapatite or in the presence of fluoride ions, fluorapatite, or fluorhydroxyapatite.
This process is consistent with the increased mineralization observed in the osteoblast-like cell lines on the addition of CPP-ACP/ CPP-ACFP in this study. These results are also consistent with a previous investigation demonstrating an increase in ALP activity and the presence of calcified nodules in CPP-Ca treated human osteoblast-like cells (10) . CPPs have been shown to not only stabilize bioavailable calcium and phosphate ions (8, 15) but also induce uptake of Ca 2+ and cellular differentiation (10, 11, 16) . Furthermore, Ca 2+ is an efficient regulator of several cellular activities such as mineralization and expression of OC and collagen (5, (17) (18) (19) . Hence, it is possible that many of the cellular effects of CPP-ACP and CPP-ACFP may be explained by the significant increase in bioavailable Ca 2+ concentration. To investigate differentiation of the osteoblast-like MG-63 and MC3T3 cells into mature osteoblasts, cells were cultured for 14 days in osteogenic media with or without CPP-ACP or CPP-ACFP. In general, exposure of MG-63 and MC3T3-E1 cells to CPP-ACP/CPP-ACFP increased the expression of Col 1 and OC and decreased the expression of OP. Col 1 is an important factor for the development of a mature osteoblastic phenotype, ie, differentiation and mineralization, and it is the predominant product of osteoblasts, representing 95% of extracellular non-mineral bone matrix (20, 21) . The expression of OC, a bonespecific protein and marker of osteogenic maturation, occurs subsequent to initiation of ALP activity and accompanies mineralized tissue formation (22, 23) . Col 1 together with OC contributes to the initiation of nucleation and hierarchical assembly of apatite within the collagen scaffold, a critical process in bone formation (24) . The increase in mineralization and increased expression of Col 1 and OC by exposure of osteoblast-like cells to CPP-ACP/CPP-ACFP observed in this study are consistent with this proposed mechanism of Control, 1.5% CPP-ACP, 3% CPP-ACP, 1.5% CPP-ACFP, 3% CPP-ACFP. *Denotes significant differences compared with control. mineralization initiation. OP is not detected with bone formation, because its synthesis is closely associated with initiation and mediation of bone resorption (25) . OP, a strong inhibitor of the mineralization process, has the ability to bind to apatite crystals, inhibiting their growth (26) . As such, the decrease in expression of OP and increase of Col 1 and OC shown in this study support CPP-ACP and CPP-ACFP favoring bone formation.
IL-1 cytokines are responsible for the production of sterile inflammation (27) . However, there was no evidence that either CPP-ACP or CPP-ACFP triggered an inflammatory response in the osteoblast-like and fibroblast-like cell lines, because no IL-1a could be detected. This is consistent with the known biocompatibility of these nanocomplexes. The production of IL-6 by the osteoblast-like cell lines was significantly increased by incubation with CPP-ACP and CPP-ACFP media. Although IL-6 is believed to be an osteolytic factor (28) , it has an important role in osteoblastic differentiation by enhancing ALP activity (29, 30) . IL-6 is produced by osteoblasts stimulated by growth factors, and it has a role in osteoclast formation and recruitment important for reparative and physiologic bone remodeling (31, 32) . IL-6 also plays a role in osteoblast formation in situations of high bone turnover (33) . Calcium-enriched CPP has been reported to act as a modulator of the intestinal immune system, triggering cytokine secretion such as IL-6, attributed to elevated levels of Ca 2+ (34, 35) . Therefore, taken together, the most likely explanation for the present findings is that CPP-ACP and CPP-ACFP provided an elevated bioavailable Ca 2+ concentration that triggered production of IL-6, subsequently inducing ALP activity, osteoblastic differentiation, and mineralization. The differences between CPP-ACP and CPP-ACFP in inducing mineralization and secretion of IL-6, Col 1, and OC may be attributable to the superior mineralization potential of CPP-ACFP (9).
Conclusion
Both CPP-ACP and CPP-ACFP are biocompatible with the potential to induce osteoblastic differentiation and calcification/mineralization. These findings may support the use of these materials as bioactive additives to endodontic cements to promote hard tissue regeneration as well as a calcification barrier in vital pulp therapy. Further research is indicated to directly compare calcium silicate-based materials with and without the addition of CPP-ACP or CPP-ACFP.
